Xylazine prevalence and concentration in the Los Angeles fentanyl market, 2023-2025.

Saved in:
Bibliographic Details
Title: Xylazine prevalence and concentration in the Los Angeles fentanyl market, 2023-2025.
Authors: Friedman J; Department of Psychiatry, University of California, San Diego, United States., Molina CA; Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, United States., Koncsol AJ; Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, United States., Romero R; Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, United States., Godvin ME; Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, United States., Jalayer E; Bienestar Human Services, Los Angeles, CA, United States., Davila S; Community Health Project LA, Los Angeles, CA, United States., Arellano O; Homeless Outreach Program Integrated Care System, Los Angeles, CA, United States., Cowan A; Community Health Project LA, Los Angeles, CA, United States., Hurley B; Department of Public Health, Los Angeles, CA, United States., Shover CL; Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, United States.
Source: Drug and alcohol dependence reports [Drug Alcohol Depend Rep] 2025 Jul 22; Vol. 16, pp. 100364. Date of Electronic Publication: 2025 Jul 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918350383506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-7246 (Electronic) Linking ISSN: 27727246 NLM ISO Abbreviation: Drug Alcohol Depend Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2772-7246
DOI:10.1016/j.dadr.2025.100364